CibulkaR,RacekJ,VeselaE., 2005.The importance of L-carnitine in patients with chronic renal failure treated with hemodialysis,Vnitr Lek 51 1108 -13
LeveyAS,CoreshJ,BalkE,KauszAT,LevinA,SteffesMW, 2003.National kidney foundation practice guidelines for chronic kidney disease: evaluation, classification and stratification,Ann Intern Med 139 137 -47
SalgadoJV,NevesFA,BastosMG,FrançaAK,BritoDJ,SantosEM, 2010.Monitoring renal function: measured and estimated glomerular filtration rates-a review,Braz J Med Biol Res 43 528 -36
AddabboF,MallamaciF,LeonardisD,TripepiR,TripepiG,GoligorskyMS, 2007.Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function,Nephrol Dial Transplant 22 3521 -6
SreenivasuluU,BhagyammaSN,AnuradhaR, 2016.Study of serum electrolyte changes in end stage renal disease patients before and after hemodialysis sessions: a hospital based study,Sch Acad J Biosci 4 283 -7
ShankaliaDM,TannaAC, 2013.Role of hemodialysis in renal failure to correct biochemical parameters,Indian J Appl Res 3 414 -6
VaranHI,DursumB,DursumE,OzbenT,SuleymanlarG, 2010.Acute effects of hemodialysis on oxidative stress parameters in chronic uremic patients: comparision of two dialysis membranes,Int J Nephrol Renovasc Dis 3 39 -45
AkdagI,YilmazY,KahveciogluS,BolcaN,ErcanI,ErsoyA, 2008.Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: A 5-year prospective study,Nephron Clin Pract 108 C99 -105
GuptaK,MahajanR, 2011.Coronary risk factors in maintenance hemodialysis patients: Who is the culprit -hemodialysis or chronic renal failure?,Int J Appl Basic Med Res 1 11 -4
JonesMK,CatteA,LiL,SegrestJP, 2009.Dynamics of activation of lecithin: cholesterol acyltransferase by apolipoprotein A-I,Biochemistry 48 11196 -210
MaheshwariN,AnsariMR,DarshanaMS,LalK,AhmedK., 2010.Pattern of lipid profile in patients on maintenance hemodialysis,Saudi J Kidney Dis Transpl 21 565 -70
ZoccaliC,KramerA,JagerKJ, 2010.Chronic kidney disease and endstage renal disease-a review produced to contribute to the report 'the status of health in the European Union: towards a healthier Europe' NDT Plus, 3 213 -24
TsimihodimosV,DounousiE,SiamopoulosKC, 2008.Dyslipidemia in chronic kidney disease: An approach to pathogenesis and treatment,Am J Nephrol 28 958 -73
RajuSSK,LalithaDL,KiranmayiP., 2013.A study of lipid profile and lipid peroxidation in chronic kidney disease with special reference to hemodialysis,J Clin Res Bioeth 4 143 -
2016.Dyslipidemia in chronic renal failure: Cause or effect?,Asian J Med Sci 7 42 -6
VaziriND,NorrisK., 2011.Lipid disorders and their relevance to outcomes in chronic kidney disease,Blood Purif 31 189 -96
AttmanPO,SamuelssonO,JohanssonAC,MoberlyJB,AlaupovicP, 2003.Dialysis modalities and dyslipidemia,Kidney Int Suppl 84 S110 -2
CibulkaR,RacekJ, 2007.Metabolic disorders in patients with chronic kidney failure,Physiol Res 56 697 -705
KaysenGA, 2006.Dyslipidemia in chronic kidney disease: Causes and consequences,Kidney Int 70 S55 -8
VaziriND, 2006.Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences,Am J Renal Physiol 290 262 -72